Measles Vaccination Rates Dropped During COVID-19 Pandemic to 81% in 2021
The rate of children receiving a first measles-containing vaccine decreased between 2020 and 2021, CDC says.
Allergy and Immunology Information Center
Epicutaneous Immunotherapy Safe, Effective in Toddlers With Peanut Allergy
The phase 3 EPITOPE trial assessed the safety and efficacy of epicutaneous immunotherapy for peanut allergy in children under 4 years old.
Needle-Free Epinephrine Delivery Would Lead to Faster Allergy Response
A survey explored triggers for use of epinephrine injection devices and why patients with allergies and their caregivers often delay epinephrine administration.
COVID-19 Vaccines Up Protection More Than Infection for Moms, Infants
Antibody levels higher in maternal and cord blood after vaccination vs natural infection.
High-Dose Superior to Standard-Dose Influenza Vaccination in Older Adults
Lee EH, Lee KH, Kim J, et al. Comparing different delivery methods of fecal microbiota transplantation. Presented at: IDWeek 2022; October 19-23, 2022; Washington, DC. Poster 515.
FDA Authorizes Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted
Findings showed that the booster dose elicited robust antibody responses comparable to, or exceeding levels associated with the efficacy data in the primary series of the vaccine.
Infections Reported After Single Dose of Monkeypox Vaccine
Most of the cases of monkeypox occurring following single dose of the MVA-BN vaccine occur within 14 days.
Vaccine-Associated Aluminum Linked to Persistent Asthma in Young Children
Positive association seen for children with and without eczema; CDC is not changing current vaccine recommendations.
Trial Evaluating Pfizer’s Quadrivalent mRNA Influenza Vaccine Begins
The quadrivalent modRNA influenza vaccine candidate uses mRNA technology, which requires only the genetic sequence of the virus.
COVID-19 Boosters, Third Doses Well Tolerated Among Pregnant, Lactating People
Most individuals (82.8%) reported a local reaction after a COVID-19 booster or third dose, and 67.9% reported at least one systemic symptom.
New York Declares State Disaster Emergency Due to Circulating Polio Evidence
A State Disaster Emergency was declared in New York due to evidence of circulating poliovirus.
Maternal Vaccine Candidate for GBS Prevention in Infants Gets Breakthrough Tx Status
GBS6 is an investigational maternal vaccine designed to protect against the 6 most prominent GBS serotypes.
Flu Shot Recommended for All Children ≥6 Months, Early in Season
The AAP recommends annual vaccination against influenza for all children without medical contraindications, starting at age 6 months.
ACIP: Updated Vaccine Guidance for the 2022-2023 Influenza Season
In general, routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications and should be completed by the end of October.
Will Omicron-Specific Booster Shots Be More Effective at Combating COVID-19?
Researchers answer 5 questions about the new Omicron booster shots that may be FDA-approved for use this fall.
FDA Authorizes Use of Novavax COVID-19 Vaccine, Adjuvanted in Adolescents
The FDA has expanded the EUA for the Novavax COVID-19 Vaccine, Adjuvanted to include adolescents 12 to 17 years of age to prevent COVID-19.
Nurse-Led Interventions May Cut Children’s Fear of Needles
Divided attention and positive memory reframing are feasible and may reduce vaccine-related distress in children
UK Is First Country to Approve Moderna Omicron-Targeted Vaccine
Updated vaccine targeted to the Omicron variant is expected to have “important role” in protecting people from COVID-19 this winter
Poliovirus Discovered in NYC Wastewater
Discovery of poliovirus in sewage samples suggests there is already community transmission of the virus.
Dupilumab Plus House Dust Mite Sublingual Immunotherapy for Allergic Asthma
Can combining dupilumab with house dust mite sublingual immunotherapy effectively control asthma in patients with HDM-related asthma and allergic rhinitis?
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Allergy and Immunology Information Center
Loading... 
Loading...